Status:
RECRUITING
Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms
Lead Sponsor:
University of Chile
Conditions:
Schizophrenia
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
Schizophrenia patients have deficits of different degrees in several cognitive domains, impacting their social functioning and quality of life. Cognitive remediation strategies are useful to treat cog...
Detailed Description
Schizophrenia is a severe psychiatric illness that has a significant impact on patients, their families, and society. It presents with deficits of different degrees in all cognitive domains, including...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia according to Diagnostic and Statistical Manual (DSM)-5
- Age between 18 and 59 years
- Clinically stable outpatients
- Current treatment with at least one antipsychotic medication
Exclusion
- Significant medical or neurological comorbidity
- Substance use disorder with illegal drugs in active use
- Participation in a cognitive remediation program in the last 6 months
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06482918
Start Date
June 1 2024
End Date
March 15 2026
Last Update
July 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Psiquiatrica Universitaria, Hospital Clinico de la Universidad de Chile
Santiago, RM, Chile